GlobeNewswire: SANUWAVE Health, Inc. Contains the last 10 of 263 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T01:56:10ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/02/22/2834143/0/en/SANUWAVE-Health-Reports-Stockholder-Approval-of-SEPA-Merger-at-Special-Meeting-of-Stockholders.html?f=22&fvtc=4&fvtv=16186SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders2024-02-22T22:00:00Z<![CDATA[At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 “for” and 5,221,765 “against” with 71,525 abstaining]]>https://www.globenewswire.com/news-release/2024/01/22/2812968/0/en/SANUWAVE-Announces-Special-Meeting-of-Stockholders-to-Vote-on-Business-Combination-with-SEP-Acquisition-Corp-Nasdaq-SEPA.html?f=22&fvtc=4&fvtv=16186SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)2024-01-22T12:59:23Z<![CDATA[EDEN PRAIRIE, MN, Jan. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the Company is holding a special meeting of stockholders on February 21, 2024 at 10:00 a.m. CT (11:00 a.m. ET) to vote on the previously announced merger with SEP Acquisition Corp (“SEPA”).]]>https://www.globenewswire.com/news-release/2024/01/10/2806979/0/en/SANUWAVE-Health-Announces-Preliminary-Revenue-Results-for-the-Fourth-Quarter-and-Fiscal-Year-2023-Ended-December-31-2023.html?f=22&fvtc=4&fvtv=16186SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 20232024-01-10T12:00:00Z<![CDATA[SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023. This represents a new quarterly revenue record for the Company.]]>https://www.globenewswire.com/news-release/2023/11/10/2778128/0/en/SANUWAVE-Announces-Q3-2023-Financial-Results.html?f=22&fvtc=4&fvtv=16186SANUWAVE Announces Q3 2023 Financial Results2023-11-10T10:00:00Z<![CDATA[EDEN PRAIRIE, MN,, Nov. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 3rd quarter 2023 results.]]>https://www.globenewswire.com/news-release/2023/11/08/2776761/0/en/SANUWAVE-Will-Host-a-Conference-Call-on-November-10-2023-at-8-00-AM-ET-to-Present-the-Q3-2023-Financial-Results.html?f=22&fvtc=4&fvtv=16186SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results2023-11-08T21:30:00Z<![CDATA[EDEN PRAIRIE, MN, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, November 10, 2023, at 8:00AM (ET) to present the Q3 2023 financial results.]]>https://www.globenewswire.com/news-release/2023/10/10/2757354/0/en/SANUWAVE-Health-Announces-Preliminary-Revenue-Results-for-the-Third-Quarter-Ended-September-30-2023.html?f=22&fvtc=4&fvtv=16186SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 20232023-10-10T11:30:00Z<![CDATA[SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30, 2023]]>https://www.globenewswire.com/news-release/2023/08/23/2730735/0/en/SANUWAVE-Health-Inc-a-Leading-Provider-of-FDA-Approved-Next-Generation-Wound-Care-Products-Enters-into-a-Merger-Agreement-with-Sweat-Equity-Partners-and-Mercury-Life-Sciences-affil.html?f=22&fvtc=4&fvtv=16186SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company2023-08-23T20:30:00Z<![CDATA[· SANUWAVE Health Inc. (OTCQB: SNWV) has entered into a definitive merger agreement with SEP Acquisition Corp. (Nasdaq: SEPA). Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol “SNWV”.]]>https://www.globenewswire.com/news-release/2023/08/11/2723406/0/en/SANUWAVE-Announces-Q2-2023-Financial-Results.html?f=22&fvtc=4&fvtv=16186SANUWAVE Announces Q2 2023 Financial Results2023-08-11T10:00:00Z<![CDATA[EDEN PRAIRIE, MN, Aug. 11, 2023 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 2nd quarter 2023 results.]]>https://www.globenewswire.com/news-release/2023/08/09/2722217/0/en/SANUWAVE-Will-Host-a-Live-Conference-Call-on-August-11-2023-at-8-30-AM-EDT-to-Present-Its-Q2-2023-Financial-Results.html?f=22&fvtc=4&fvtv=16186SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results2023-08-09T21:22:23Z<![CDATA[EDEN PRAIRIE, MN, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 11, 2023, at 8:30AM (EDT) to present its Q2 2023 financial results.]]>https://www.globenewswire.com/news-release/2023/08/01/2715700/0/en/SANUWAVE-Signs-Distribution-Agreement-With-Pacific-Medical-Inc.html?f=22&fvtc=4&fvtv=16186SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.2023-08-01T11:30:00Z<![CDATA[Pacific Medical to bring its sales force of over 215 dedicated representatives covering seven western states to the SANUWAVE UltraMist line of directed energy wound care products.]]>